The four-part lecture focused on clinical trial from a regulatory affairs perspective. Mr. Henry Yau (Managing Director of the HKU Clinical Trial Centre), Ms. Kim Lee (Lead of the HKAPI Clinical Trial Taskforce), Mr. Vincent Chiang (Senior Pharmacist (Drug Import and Export) of the Drug Office) and Mr. Clement Ngai (partner of Baker & McKenzie Shanghai) spoke on such topics as research and regulatory development of clinical trials in Hong Kong and Mainland China, gave practical case studies on how to submit an NCE application using phase 2B clinical data, as well as important notes surrounding the application for Certificate for Clinical Trial/Medicinal Test in Hong Kong.